Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping

NCT07250737 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Muscular Disorders, Atrophic
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Muscular Dystrophies
Muscular Dystrophy, Duchenne

Interventions

DRUG: delpacibart zotadirsen

Sponsor

Avidity Biosciences, Inc.

Collaborators

Clinigen Healthcare Limited